# US 2026/0124406 A1 · Preparation Kit for Biologic Treatments and Method for Use of Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0124406 A1
- Document ID: US20260124406A1
- Status: Published application
- Kind: A1
- Application number: 18/938,796
- Filed: 2024-11-06
- Published: 2026-05-07
- Earliest claimed: 2024-11-06
- Assignees: Quintessence Biologics Inc.
- Applicants: Quintessence Biologics Inc.
- Inventors: Sagar Nepal
- Web page: https://patentgrep.com/patent/US20260124406A1

## CPC

- A61M 11/007: {Syringe-type or piston-type sprayers or atomisers}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/0021: {Intradermal administration, e.g. through microneedle arrays or needleless injectors}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 9/12: Aerosols; Foams {(A61K9/0043, A61K9/0056, A61K9/006, A61K9/0073 take precedence; spray-films A61K9/7015)}
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61M 2202/0462: Placental blood, umbilical cord blood
- A61M 2202/0468: non-physiological
- A61M 2210/04: Skin
- A61M 2210/06: Head
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A preparation kit and method for reconstituting and delivering biologic treatments derived from human umbilical cord and amniotic membrane tissue. The kit includes a vial containing lyophilized biologic material, a removable seal, and a spray nozzle with a removable cap to maintain sterility. A container holds a humectant solution comprising glycerol, hyaluronic acid, or a combination thereof. In use, the humectant solution is added to the vial, the biologic material is mixed, and the spray nozzle is used for aesthetic application to human skin or hair. The vial is made of glass or medical-grade plastic to prevent contamination. The spray nozzle delivers a measured dose ranging from 0.5 mL to 5 mL. The method involves removing the seal, adding the humectant solution, attaching the spray nozzle, mixing the components, and applying the biologic via spray.

## Claims

### Claim 1

A preparation kit for biologic treatments, comprising:
a vial containing at least one lyophilized biologic material derived from at least one of human umbilical cord and amniotic membrane tissue;
a removable seal configured to close the vial;
a spray nozzle attachable to the vial;
a container holding a humectant solution, the humectant solution being one of a glycerol-based material and a hyaluronic acid-based material;
wherein, in use, the removable seal is removed, the liquid material is added to the vial, the spray nozzle is attached, and the lyophilized biologic material and the humectant solution are mixed to reconstitute a biologic for aesthetic application by way of the spray nozzle to one of human skin and human hair.

### Claim 2 (depends on 1)

The preparation kit as recited in claim 1, wherein the spray nozzle further comprises a removable cap for maintaining sterility prior to use.

### Claim 3 (depends on 1)

The preparation kit as recited in claim 1, wherein the humectant solution added to the vial is a combination of glycerol and hyaluronic acid.

### Claim 4 (depends on 1)

The preparation kit as recited in claim 1, wherein the vial is made of a material selected from the group consisting of glass and medical-grade plastic to ensure compatibility with the biologic and prevent contamination.

### Claim 5 (depends on 1)

The preparation kit as recited in claim 1, wherein the vial is made of borosilicate glass to ensure compatibility with the biologic material and prevent contamination

### Claim 6 (depends on 1)

The preparation kit as recited in claim 1, wherein the spray nozzle is configured to deliver a measured dose of the biologic material, wherein the dose ranges from 0.5 mL to 5 mL per spray.

### Claim 7 (depends on 1)

The preparation kit as recited in claim 1, wherein the biologic material is configured for post-treatment applications in aesthetic procedures, including CO2 laser resurfacing, microneedling, microdermabrasion, and chemical peels, to reduce downtime and enhance procedural outcomes.

### Claim 8 (depends on 1)

The preparation kit as recited in claim 1, wherein the humectant solution, comprising glycerol or hyaluronic acid, enhances the hydrophilic properties and penetration of the biologic material for improved absorption upon application.

### Claim 9

A preparation kit for biologic treatments, comprising:
a vial containing at least one lyophilized biologic material derived from at least one of human umbilical cord and amniotic membrane tissue;
a removable seal configured to close the vial;
a spray nozzle attachable to the vial, the spray nozzle further comprising a removable cap for maintaining sterility prior to use;
a container holding a humectant solution, the humectant solution being one of a glycerol-based material, a hyaluronic acid-based material, and a combination of glycerol and hyaluronic acid;
wherein the vial is made of a material selected from the group consisting of glass and medical-grade plastic to ensure compatibility with the biologic and prevent contamination;
wherein, in use, the removable seal is removed, the humectant solution is added to the vial, the spray nozzle is attached, and the lyophilized biologic material and the humectant solution are mixed to reconstitute a biologic for aesthetic application by way of the spray nozzle to one of human skin and human hair;
wherein the spray nozzle is configured to deliver a measured dose of the biologic material, wherein the dose ranges from 0.5 mL to 5 mL per spray; and
wherein the vial containing the lyophilized biologic material and the container holding the humectant solution are stored at room temperature before use, and wherein, after reconstitution, the biologic solution is ideally applied immediately or refrigerated at 2°C to 8°C and used within 72 hours.

### Claim 10

A method for preparing a biologic treatment for aesthetic application to one of human skin and human hair, the method comprising:
providing a vial containing at least one lyophilized biologic material derived from at least one of human umbilical cord and amniotic membrane tissue;
removing a removable seal from the vial;
adding a humectant solution to the vial, the humectant solution being one of a glycerol-based material, a hyaluronic acid-based material, or a combination of glycerol and hyaluronic acid;
attaching a spray nozzle to the vial;
mixing the lyophilized biologic material and the humectant solution to reconstitute the biologic material; and
spraying the reconstituted biologic material through the spray nozzle for aesthetic application to one of human skin and human hair.

### Claim 11 (depends on 10)

The method as recited in claim 10, further comprising the step of placing a removable cap over the spray nozzle to maintain sterility prior to use.

### Claim 12 (depends on 10)

The method as recited in claim 10, wherein the humectant solution is a combination of glycerol and hyaluronic acid to improve moisture retention and extend the effective application time of the biologic material.

### Claim 13 (depends on 10)

The method as recited in claim 10, wherein the vial is made of a material selected from the group consisting of glass and medical-grade plastic to ensure compatibility with the biologic material and prevent contamination.

### Claim 14 (depends on 10)

The method as recited in claim 10, wherein the spray nozzle is configured to deliver a measured dose of the biologic material, wherein the dose ranges from 0.5 mL to 5 mL per spray.
